Fimea committees

The Supervision Committee is tasked with the consideration of matters concerning the issue of licences for the industrial manufacture of medicinal products, medicinal product wholesale dealer's licences, blood service licences and pharmacy licences as well as the withdrawal of these licences and any disciplinary measures.

The task of the Pharmacopoeia Committee is to submit proposals and statements on issues concerning pharmacopoeia. All of the committees serve a term of three years at a time.

Members of the Supervision Committee

Term from 7 November 2018 to 6 November 2021

Chair
Eeva Leinonen, Head of Unit

Vice-chair
Anna von Bonsdorff-Nikander, Senior Pharmaceutical Inspector

Director Members and deputy members

Jussi Holmalahti, Director, National Supervisory Authority for Welfare and Health (Maarit Mikkonen, Head of Unit, National Supervisory Authority for Welfare and Health)
Tuula Sandholm, Leading Legal Counsel (Risto Salmi, Consulting Legal Advisor)
Vesa Mustalammi, Senior Medical Officer (Tom Wikberg, Senior Specialist)

Members of the Pharmacopoeia Committee

Term from 1 March 2019 to 28 February 2022

Chair
Head of Unit Marjo-Riitta Helle

Vice-chair Professor Jari Yli-Kauhaluoma, University of Helsinki, Faculty of Pharmacy

Members
Senior QA Advisor, Quality Management Leena From, Orion Corporation
Head of Laboratory Tuula Hauta-aho, University pharmacy, Analytical Laboratory
Director of Division Mervi Lankinen, FRC Blood Service, Laboratory services
University lecturer Katja Pajula, University of Eastern Finland, The School of Pharmacy
Senior Researcher Jukka Pakkanen
Academy Research Fellow Päivi Tammela, University of Helsinki, Faculty of Pharmacy

Secretary
Head of Section Piia Salo